Lanean...
T2 mapping of molecular subtypes of WHO grade II/III gliomas
BACKGROUND: According to the new WHO classification from 2016, molecular profiles have shown to provide reliable information about prognosis and treatment response. The purpose of our study is to evaluate the diagnostic potential of non-invasive quantitative T2 mapping in the detection of IDH1/2 mut...
Gorde:
| Argitaratua izan da: | BMC Neurol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947951/ https://ncbi.nlm.nih.gov/pubmed/31914945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-019-1590-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|